The purpose of this study is to determine whether combination of ketamine plus electroconvulsive therapy improves depressive symptoms decreasing cognitive side effects.
Topic Depression
Country Brazil
Visit trial
Status
Withdrawn
Results Published
Start date
01 January 2014
End date
01 January 2016
Chance of happening
0%
Phase
Not Applicable
Design
Blinded
Type
Interventional
Generation
First
Participants
0
Sex
All
Age
18- 99
Therapy
No
Trial Details
This study will compare the clinical response to brief pulse ECT with infusion of ketamine 0.5 mg/kg versus brief pulse electroconvulsive therapy with infusion of placebo (saline) in major depression. We also will compare levels of cognitive impairment among these groups, compare levels of quality of life among these groups, compare levels of BDNF among these groups. We also will study if levels of 25-hydroxyvitamin D are associated with cognitive impairment in subjects undergoing ECT.NCT Number NCT02012335
Sponsors & Collaborators
Hospital de Clinicas de Porto AlegreThis company doesn't have a full profile yet, it is linked to a clinical trial.
Measures Used
Hamilton Depression Rating ScaleThe Hamilton Depression Rating Scale (HDRS) is a multiple item questionnaire used to provide an indication of depression, and as a guide to evaluating recovery. The scale consists of 17 items which each item being scoring on a 3 or 5 point scale. The higher the score, the more likely a person is depressed.